The non-autotransferring plasmid NTP113 codes for production of colonization factor antigen I and heat-stable enterotoxin. NTP113, which has a molecular weight of 58 x 106, was digested with BamHI, EcoRI, and HindIII and combinations of these restriction endonucleases, and the products of these digestions were analyzed by agarose gel electrophoresis. The results were used to construct a partial restriction map of NTP113. Transposons coding for resistance to ampicillin, kanamycin, and tetracycline were inserted into NTP113, and we obtained a series of deletion mutants, as determined by the loss of tetracycline or kanamycin resistance from strains carrying the insertion mutants. A number of plasmid mutants obtained by insertion or deletion did not code for colonization factor antigen I, but most of these mutants still coded for heat-stable enterotoxin production. The positions of the inserted transposons and of the deletions were determined on the restriction map. Two regions of NTP113 were required for the expression of colonization factor antigen I, and the two sites were separated by a length of DNA corresponding to a molecular weight of about 25 x 106.
Some enterotoxigenic strains of Escherichia coli produce specific surface antigens that are responsible for adhesion to intestinal epithelial cells. Colonization factor antigen I (CFAII) and CFA/II have been identified in enterotoxigenic strains isolated from humans with diarrhea (6, 7, 11, 13, 15, 17, 32) . K88 and 987P antigens are found in strains of porcine origin (30, 34) , and K99 antigen has been identified in E. coli strains from calves and lambs (33) . These antigens are serologically distinct fimbrial structures that can be detected by mannose-resistant hemagglutination (MRHA) of different types of erythrocytes (12, 21, 32, 33) . Type 1 fimbriae are also produced by many E. coli strains (10) ; these fimbriae can be detected by mannose-sensitive hemagglutination of guinea pig erythrocytes and also differ serologically from the other fimbriae described above.
The syntheses of K88, K99, CFAII, and CFA/ II are determined by plasmids (13, 31, 35, 40) . The presence of CFA/I in strain H10407, serotype 078:H11, was correlated with a plasmid having a molecular weight of 60 x 106 (13) .
Further studies have shown that in several strains belonging to serogroup 078, including strain H10407, a single plasmid codes for production of CFA/I and heat-stable enterotoxin (ST) and that a CFA/I-ST plasmid, NTP113, is mobilized by R-factor R1-19K-to E. coli K-12 from one of these strains (39) . Mobilization of CFA/I-ST plasmids to E. coli K-12 has now been demonstrated with several other strains of serogroup 078 (24) and also with a strain belonging to serotype 0128:H12 (36) . In addition, a plasmid coding for the production of heat-labile enterotoxin (LT), as well as CFA/I and ST, has been mobilized from a strain of 063:H-; the genetic properties of the CFA/I-ST plasmids and the CFAII-ST-LT factor are very similar (24) .
We characterized the CFA/I-ST plasmid NTP113 which was mobilized from strain E7473, serotype 078: H12, in more detail in order to identify the regions that coded for production of CFA/I and ST. We examined NTP113 and mutants obtained by insertion of transposons or deletion by restriction enzyme analysis. In this paper we describe a restriction map of NTP113; it appears that two regions of the plasmid are required for expression of CFA/I.
MATERIALS AND METHODS
Bacterial strains and plasmids. The E. coli K-12 strains used in the conjugation and transposition experiments were strains 14R519 (K-12 F-lac pro trp his Nall), 21R868 (K-12 F-lac+ Strr), 14R525 (K-12 Flac+ Nalr), and AB1157. The non-autotransferring CFA/I-ST plasmid NTP113 was mobilized by the R factor R1-19K-from E. coli E7473, serotype 078: H12, which was isolated in South Africa (39) . The genetic properties of NTP113 and the other CFA/I-ST plasmids have been described previously (24) . The R-factor R1-16 (28) and the heat-lable enterotoxin plasmid TP236-Tc (25) were also used to mobilize nonautotransferring plasmids. R1-19K-codes for resistance to ampicillin (Ap), chloramphenicol (Cm), streptomycin (Sm), and sulfathiazole (Su). R1-16 codes for kanamycin resistance (Km), and TP236-Tc codes for tetracycline resistance (Tc).
Resistance to antibacterial agents. Strains were tested for drug resistance as described previously (1) .
Enterotoxin tests. ST was detected by the infant mouse assay (9) .
Hemagglutination and Immunodiffuson tests. The presence of CFAII was determined by MRHA of human or bovine erythrocytes and by immunodiffusion with a specific CFA/I antiserum, as described previously (6, 24) . Strains tested only by hemagglutination are referred to below as MRHA+ or MRHA-, whereas strains examined for CFA/I by immunodiffusion tests in addition to hemagglutination tests are referred to as CFA/I+ or CFA/I-. (ii) Moblization of non-autotranserring plasmids.
Broth cultures of an E. coli K-12 strain carrying the R factor used for mobilization and a K-12 strain carrying the non-autotransferring plasmid were mixed in equal volumes, and the mixtures were incubated overnight at 37°C; 1 ml of a culture of the final K-12 recipient was added to 2 ml of the mating mixture. After overnight incubation, the mating mixture was plated onto drugcontaining MacConkey agar. Preparation of plamid DNA. (I) Partaly purified DNA. Plasmid-carrying strains of E. coli K-12 were grown in 50-ml volumes of nutrient broth. The bacteria were lysed with a mixture of Brij 58 and sodium deoxycholate (5) , and plasmid DNA was partially purified by phenol extraction of cleared lysates (26) . Crude plasmid DNA for restriction enzyme digestions was obtained from cleared lysates that were treated with 1% (vol/vol) diethylpyrocarbonate. After 20 min at 65°C, denatured protein was removed by centrifugation, and the plasmid DNA was precipitated with ethanol in the presence of 0.2 M NaCl at -10°C for 16 h.
(H) Pure plamid DNA. Bulk preparations of pure plasmid DNA from NTP113 or its derivatives were obtained from 500-ml cultures. Plasmid DNA was precipitated from cleared lysates with polyethylene glycol 6000 and purified by cesium chloride-ethidium bromide dye-buoyant density gradient centrifugation (20) .
Treatment with restriction endonudeases. Pure or partially purified plasmid DNA preparations were dialyzed for 36 h against 0.01 M Tris-hydrochloride ( Agarose gel electrophoresis. The molecular weights of NTP113 derivatives were determined by electrophoresis of partially purified plasmid DNA preparations on vertical slab gels containing 0.6% (wt/vol) agarose (type II; Sigma Chemical Co.) (44) . These gels were run for 4 h at 140 V in 89 mM Tris buffer (pH 8.0) containing 89 mM boric acid and 2.5 mM EDTA. The fragnents produced by restriction endonuclease treatments were analyzed as described previously (43) (2) carrying TnA was used for transposition of ampicillin resistance. This TnA was derived from non-autotransferring plasmid NTP21 (26) . F-TAp was transferred into K-12(NTP113), and transconjugants were tested for MRHA and drug resistance. MRHA+ApITcr strains were treated with acridine orange (75 pglml) (16) , and cultures were plated onto media containing 100 ,ug of ampicillin per ml. Colonies were tested by replica plating for the loss of tetracycline resistance. Strains that were Apr Tc' and still MRHA+ were first tested for direct transfer of drug resistance, and if the strains were positive, they were discarded since the CFA/I-ST plasmid NTP113 is nonautotransferring. Strains (i) Iserton of a second transpobon into derivatives of NTP113. NTP119 is a derivative of NTP113 which carries TnS (see Table 3 ). This plasmid was used to obtain additional derivatives carrying TnA or TnlO, which codes for tetracycline resistance (14) .
NTP119 was mobilized by TP236-Tc into an E. coli K-12 strain carrying TnA on the bacterial chromosome. This transposon was derived from non-autotransferrng plasmid NTP21. The resulting strains were mated with K-12, and transconjugants were selected on a medium containing ampicillin and kanamycm; the frequency was usually between 10-6 and 10-. If TnA had tiansposed onto NTP119, the resulting plasmid should have coded for ampicillin resistance and kanamycin resistance. NTP119-Ap derivatives were identified, and 20 of these derivatives were used in further studies. Similar experiments were performed with a K-12 strain carrying TnlO on the chromosome; the R factor R1-19K-was used to mobilize NTP119 and the NTP119-Tc derivatives.
Transcorjugants that were resistant to kanamycin and tetracycline were obtained at frequencies of 10-6 to 10-8, and 34 NTP119-Tc derivatives were used in further tests.
Strains carrying derivatives of NTP113 with different transposons were tested for MRHA and for ST production by using the infant mouse assay.
Formation of ddelon mutants. Deletions of plasmid DNA result from excision of TnlO (23) . Three strains carrying NTP119 with different TnlO insertions were examined. Cultures were grown in nutrient broth, and suitable dilutions were plated onto nutrient agar containing 20 ,ug of kanamycin per il. Colonies were examined for the loss of tetracycline resistance by replica plating. Strains which were Kmr Tcs were tested for MRHA and ST production. K-12 strains carrying NTP119-Tc derivatives were also examined for the loss of kanamycin resistance and the retention of tetracycline resistance.
Strategy for mapping NTP113 and its derivatives. Initially, NTP113 was digested with EcoRI, BamHI, and HindlHI separately and within combinations, and the sizes of the restriction fragments were measured. From double digestions we deduced the presence of sites for a second enzyme within the fragments generated by the first enzyme. The location of a cleavage site(s) within a particular fragment was then obtained by digesting the fragment after excision from LGT agarose. Similar experiments were then performed with NTP113 mutants obtained by inserting drug resistance transposons containing known sites for BamHI, EcoRl, or HindlIl. The positions of the transposon restriction sites within the restriction fragments of NTP113 were determined, and these inserted sites provided markers with which neighboring restriction sites of NTP113 were located. Combining all of these results permitted conclusions on the ordering and orientation of the BamHI fragments and most of the EcoRI fragments and on the positions of those HindII franents that contained EcoRI or BamHI sites. Finally, we performed a restriction analysis on derivatives obtained after deletion of drug resistance transposons in order to determine the regions of NTP113 DNA that had been lost and to provide further evidence to order the fragments.
Electron microscopy. Strains were grown and prepared for electron microscopy as described previously (24) .
RESULTS
Restriction enzyme analyis of NTP113. The genetic properties of CFA/I-ST plasmid NTP113 have been described previously (24) . This plasmid (molecular weight, 58 x 106) has 3 cleavage sites for BamHI, at least 9 EcoRI sites, and probably more than 17 Hindlll sites (Tables 1  and 2 ). We investigated the relationships of these sites by digesting NTP113 with combinations of these three restriction endonucleases and fractionating the products on 0.7 or 1.0o agarose gels. In addition, fragments larger than 2 x 106 generated from primary digestions separated on 0.7% LGT agarose were excised from the gels and subjected to treatment with a second enzyme. These secondary digestions were run on horizontal 1 or 1.4% agarose gels. The results of these experiments are summarized in Tables 1 and 2 .
BamHI sites were located in EcoRI fragments El, E3, and E8 (Table 1) . Among the products of double digestions with these enzymes, five fragments (designated EB2, EB4, EB5, EB6, and EB8) corresponded to the primary EcoRI fragments E2, E4, E5, E6, and E7; these contained no BamHI sites and therefore arose as internal fragnents when primary BamHI fragments were redigested with EcoRI (Table 1) .
LGT agarose analysis showed that fragment EB9 (molecular weight, 0.9 x 106) comprised two comigrating EcoRI-BamHI fragments (EB9a, derived from EcoRI fragment E3, and EB9b, derived from EcoRI fragment E8).
Treatment of NTP113 DNA with Hindlll and BamHI together showed that BamHI sites were site that the mobility of the HindIII fragment which contained it was not altered detectably after digestion with both restriction enzymes. It is also possible that the site was in a small HindIII fragment which comigrated with another fragment; in this case it would have been difficult to detect a difference between HindIII digests and HindIII-BamHI digests.
Because of the relatively large number of HindIII sites, we made no attempt to order these sites completely. However, we examined the fragments for the presence of EcoRI sites to determine the positions of the HindIII cleavage sites around the EcoRI sites ( Table 2 ). The largest HindlIl fragment (fragment H1) contained three EcoRI sites and yielded two internal fragments that were indistinguishable in size from EcoRI fragments E6 and E7. These EcoRI fragments contained no HindIlI sites (Table 2) , a finding consistent with location within HindIII fragment Hi.
Digestion of NTP113 with HindlIl and EcoRI indicated that HindlIl fragments H4, H6, H7, H8, and H12 also contained EcoRI sites, and the positions of these sites within HindIII fragments H4, H6, H7, and H8 were determined by secondary digestion of excised fragments (Table 2) . HindIII sites were present in EcoRI fragments El, E2, E3, E4, E5, and E8; Table 2 shows the molecular weights of the products of HindIII digestion of these fragments. An examination of all of these data resulted in the conclusions shown in Table 2 (Table 3 ) was formed by transposition of Tn5 onto NTP113, as described above; this plasmid coded for MRHA and ST production and had a molecular weight of 62 x 106. NTP119 has been used previously in genetic studies of CFA/I-ST plasmids (24) . NTP120 and NTP121 were obtained by transposition of TnA onto NTP113 (Table 3 ). Both of these plasmids coded for ST production, but strains carrying NTP121 were MRHA negative. Immunodiffusion tests confirmed that CFA/I was not produced by K-12(NTP121). NTP119, NTP120, and NTP121 were analyzed further to locate the positions of insertion of TnS and TnA.
Both TnS and TnA contain single cleavage sites forfiamHl (22, 37) . In both NTP119 and NTP120, insertion of the transposon occurred into EcoRI fragment E3 of NTP113 (Table 3 and Fig. 1 ). The plasmid derivatives produced four BamHI fragments, two of which were equivalent in size to BamHI fragments B2 and B3 of NTP113. NTP119 also gave a fragment having a molecular weight of 11 x 106 and one which comigrated with BamHI fragment B2, whereas NTP120 yielded fragments having molecular weights of 7 x 106 and >14 x 106. NTP121, which did not code for MRHA, was derived from NTP113 by insertion of TnA into EcoRI fragment E5 (Table 3 and Fig. 1 Table 3 we constructed a partially complete restriction map of NTP113 (Fig. 2) . The positions of EcoRI fragments E6, E7, and E9 could not be deduced with certainty because no insertions into these fragments were obtained. EcoRI fragments E6 and E7 are shown between EcoRl fragments E2 and E3 since this location is consistent with the sizes of the BamHI fragments of NTP113 and NTP122. EcoRI treatment ofHindlIl fragment Hi excised from LGT agarose yielded internal fragments that were indistinguishable in size from EcoRI fragments E6 and E7, and it is likely that these fragments may be contiguous, although their orientations are unknown. Further evidence for the locations of these fragments was obtained from an analysis of deletion mutants (see below) which were obtained by deletion of transposons TnlO and TnS from NTP113 derivatives.
Mutants obtained by deletion. (i) Loss of TnlO. Strains carrying NTP122, NTP123, and NTP124 were tested for loss of tetracycline resistance; this occurred at a frequency of about 0.2%. Tcs lines which were still kanamycin resistant were tested for MRHA and ST production. A number of the plasmid derivatives were examined in detail (Table 4) ; some of the Tcs strains were MRHA-, but all of these derivatives were still ST+.
We obtained three derivatives of NTP123 which had lost all or part of TnlO, and two of these (NTP125 and NTP126) did not code for MRHA. These plasmids had molecular weights of 40 x 106 and 48 x 106, respectively, and the amounts of DNA deleted in the formation of these plasmids are shown in Fig. 3 . In both The structure was derived from the results shown in Tables 1 and 2 and from restriction enzyme analyses of mutants obtained by the insertion (Table 3 and Fig. 1) and deletion (Fig. 1, 3 , and 4 and Table 1 ).
zyme digestion showed that NTP124 had suffered a deletion extending anticlockwise from the TnlO insertion in EcoRI fragment E4 (Fig. 2  and 4 ) to a point somewhere within EcoRI fragment E5; EcoRI-BamHI fragments EB1 and EB7 were present intact. This plasmid contained neither of the putative CFA/I regions. Plasmid NTP138 resulted from a loss of kanamycin resistance by NTP135 (Table 4) ; this derivative coded for ampicillin resistance but not for MRHA or ST production. NTP138 was the smallest spontaneously occurring deletion derivative (molecular weight, 11 x 106) and contained TnA, which was inserted into EcoRI fragment E5 of the parent plasmid (NTP135) ( Table 3) . HindhIl treatment of NTP138 yielded a fragment that was indistinguishable in size from HindIII fragment H7 of NTP113 and contained an EcoRP site corresponding to one end of EcoRI fragment E5 (Fig. 4) .
Complementation betwen CFA/I-mutants. We tested a plasmid with a mutation that mapped in CFA/I region 1 for complementation with another plasmid derivative with a mutation which mapped in CFA/I region 2. NTP128 (CFA/I-ST' Km) was mobilized by TP236-Tc into K-12 carrying NTP121 (CFA/I-ST' Ap). The mating mixture was plated onto media containing ampicillin and kanamycin, and colonies were tested for MRHA. All 10 colonies tested showed MRHA with human erythrocytes, although the reaction was weak in most cases. Four strains from this cross were grown in drug-free nutrient broth and were tested for the stability of their ampicillin resistance and kanamycin resistance. Since NTP128 and NTP121 were both derivatives of NTP113, they should have been incompatible, and segregation tests showed losses of ampicillin resistance (20%) and kanamycin resistance (45%), as expected.
Electron microscopy of srains carrying colonization factor antigen mutants. We examined E. coli K-12 strain 14R519 carrying NTP121 or NTP127 for the presence of fimbriae by electron microscopy after the strain was grown on CFA agar (12) . Of 211 K-12(NTP121) organisms, 208 (98.5%) were nonfimbriate; in the case of K-12(NTP127), 96.5% of the organisms (171 of 177) were nude. Cultures of the two strains were negative in hemagglutination tests for type 1 fimbriae when guinea pig erythrocytes were used. However, the few cells of K-12(NTP121) and K-12(NTP127) which were fimbriate probably possessed type 1 fimbriae, as observed previously with CFA/I-negative strains (24, 42) .
DISCUSSION
Previous studies have shown that in several enterotoxigenic E. coli strains a single plasmid codes for production of CFAJI and ST (24, 36, 39) . In this investigation we constructed a restriction map of the CFA/I-ST plasmid NTP113 and showed that two regions of the plasmid are required for expression of CFA/I. Electron microscopy confirmed that strains carrying plasmids with mutations in either region do not produce fimbriae. We do not know whether both regions include stuctural genes for CFAII fimbriae or whether one of them possesses a control gene(s) which is necessary for expression.
The role of CFAII in producing disease has been demonstrated in volunteer experiments with strain H10407. The derivative H10407-P, which did not produce CFA/I or ST but still produced heat-labile enterotoxin, did not cause diarrhea in these experiments (38) . It would be useful to obtain a derivative of a CFA/I-ST plasmid which does not code for ST production so that the effect of CFA/I alone could be examined. This type of mutant was not obtained in this study, although we did isolate mutants of NTP113 which did not code for CFAII or ST production. The ST gene may map very closely to CFA/I region 1, so that deletion mutants that affect ST also result in the loss of CFA/I production.
It may be possible to obtain derivatives that code for only CFA/I by cloning techniques. Genes coding for enterotoxin production or adhesive factors on a number of different plasmids have been cloned onto multicopy vector plasmids (8, 29, 41) . In the case of CFA/I this is complicated by the presence of two regions which are required for the expression of CFA/I, and these have to be cloned separately.
Strains carrying NTP128 were ST', whereas strains carrying NTP137 were ST-; both of these plasmids were about one-half the size of NTP113 (Fig. 2) . (Fig. 2) . The smallest naturally occurring NTP113 derivative, NTP138
(molecular weight, 11 x 106), also contains DNA from around the junction of EcoRI fiagments E5 and El. Therefore, the replication genes of NTP113 may be located in this region of the molecule.
Further mapping studies of NTP113 and some of the derivatives obtained in this study should result in a more precise identification of the regions associated with CFA/I, ST, replication, and other properties encoded by the plasmid. In particular, we plan to use cloning techniques to obtain derivatives which only code for CFA/I production so that the expression of the adhesion system can be examined in more detail.
